Sort by
Medicine and Dentistry
Adenoma
26%
Capsule Endoscopy
20%
Cohort Analysis
34%
Colectomy
20%
Colitis
55%
Colon
16%
Colonoscopy
17%
Colorectal Carcinoma
24%
Colorectal Polyp
13%
Combination Therapy
25%
Crohn's Disease
57%
Cytomegalovirus Infection
12%
Dextran Sulfate
23%
Disease Course
26%
Endoscopic Mucosal Resection
13%
Endoscopic Submucosal Dissection
22%
Endoscopic Surgery
21%
Endoscopy
12%
Esophagogastroduodenoscopy
15%
Esophagus
20%
Forced Expiratory Volume
20%
Hazard Ratio
37%
Inflammatory Bowel Disease
66%
Infliximab
22%
Intestine Injury
20%
Lung Cancer
20%
Mesenchymal Stem Cell
50%
Neoplasm
33%
Neuroendocrine Carcinoma
20%
Non Erosive Reflux Disease
20%
Non Small Cell Lung Cancer
20%
Nonsteroid Antiinflammatory Agent
20%
Odds Ratio
28%
Patient with Crohn's Disease
28%
Patient with Inflammatory Bowel Disease
63%
Patient with Ulcerative Colitis
33%
Polyp
32%
Predictive Factor
15%
Prevalence
44%
Prognostic Factor
31%
Recurrent Disease
39%
Reflux Esophagitis
30%
Retrospective Study
23%
Signet Ring Cell Carcinoma
20%
Squamous Cell Carcinoma
24%
TNF Inhibitor
14%
Tonsil
50%
Tumor Necrosis Factor
33%
Ulcer
12%
Ulcerative Colitis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
8%
Acute Coronary Syndrome
20%
Anti-Inflammatory Drug
13%
Benzoxazole Derivative
10%
Biological Product
11%
Bleeding
11%
C Reactive Protein
10%
Ciclosporin
10%
Colitis
94%
Colon Diverticulosis
10%
Colorectal Carcinoma
10%
Combination Therapy
32%
Coronavirinae
10%
Crohn's Disease
43%
Cytokine
29%
Dextran Sulfate
55%
Dextran Sulfate Sodium-Induced Colitis
12%
Disease Activity
24%
Disease Course
18%
End Stage Renal Disease
20%
Enteropathy
10%
Fibrosis
10%
Helicobacter Infection
10%
Helicobacter Pylori
10%
Herpes Zoster
12%
Immunomodulating Agent
13%
Inflammatory Bowel Disease
83%
Infliximab
21%
Interleukin 1
10%
Interleukin 6
15%
Intestine Injury
20%
Lung Cancer
20%
Messenger RNA
12%
Mouse Model
12%
Murine
31%
Non Small Cell Lung Cancer
20%
Non-Steroidal Anti-Inflammatory Drug
20%
Prevalence
20%
Recurrence Risk
13%
Recurrent Disease
22%
Remission
20%
Retrospective Study
23%
Therapeutic Effect
15%
Tofacitinib
10%
Troponin T
20%
Trough Level
10%
Tumor Necrosis Factor
40%
Tumor Necrosis Factor Inhibitor
26%
Ulcer
13%
Ulcerative Colitis
56%
Immunology and Microbiology
Adalimumab
10%
Cardiac Troponin
20%
Ciclosporin
10%
Colitis
84%
Colon
20%
Crohn's Disease
31%
Feces
10%
Inflammatory Bowel Disease
28%
Inflammatory Cytokine
7%
Infliximab
31%
Interleukin 6
8%
Mesenchymal Stem Cell
71%
Metabolome
5%
Mouse Model
6%
Murine
31%
Pneumocystis Jiroveci
10%
Proinflammatory Cytokine
7%
T Cell
10%
Tonsil
71%
Ulcerative Colitis
33%
